Ahead Therapeutics SL 

A tech-platform developing disease-modifying treatments to cure autoimmune diseases

OWNER

Marti Dalmases (See Profile)


Sector

Therapeutics

Stage

Prototyping, preclinical

Country

Spain


Patented technology graded in different territories: WO2015107140 and EP22383126.4

GMP-Tox Batch ready feb 2024

FiH - PoC Clinical Trial Phase Ib/II starting 2025

Strong Business Development activity, CDA with some Big Pharma Companies

Finalists at EIT Health Catapult Pitch tournament

Status

Approved

IP Type

Patent

Time

12 years

Countries

Australia
Austria
Belgium
Canada
China
Denmark
Finland
France
Germany
Israel
Italy
Japan
Netherlands
Spain
Switzerland
USA
United Kingdom

Coverage

Product patent. Claim 1: “A liposome encapsulating an autoantigen, wherein (i) the liposomes has a size comprised from 500 to 15000 nm; and (ii) the liposome membrane comprises phosphatidylserine (PS) in an amount comprised from 10 to 40% by weight with respect to the total membrane liposomal composition.”

Know more of this patent

Status

Pending

IP Type

PCT

Time

Countries

Australia
Austria
Belgium
Canada
China
Denmark
Finland
France
Germany
Israel
Italy
Japan
Netherlands
Spain
Switzerland
USA
United Kingdom

Coverage

Product patent. TOLEROGENIC COMPOSITION. Based on the innovative features discovered during the development of the Ahead’s Tech-Platform. It is based on the involvement of B Cells and scalable method of liposomes production process.

Know more of this patent

This information is confidential, do not share or copy.

Under evaluation at least till: 25th of June 2023

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar